These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29717382)

  • 61. Effects of continuous renal replacement therapy on inflammation-related anemia, iron metabolism and prognosis in sepsis patients with acute kidney injury.
    An MM; Liu CX; Gong P
    World J Emerg Med; 2023; 14(3):186-192. PubMed ID: 37152528
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Serum hepcidin in inflammatory bowel diseases: biological and clinical significance.
    Bergamaschi G; Di Sabatino A; Albertini R; Costanzo F; Guerci M; Masotti M; Pasini A; Massari A; Campostrini N; Corbella M; Girelli D; Corazza GR
    Inflamm Bowel Dis; 2013 Sep; 19(10):2166-72. PubMed ID: 23867871
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hepcidin-25/erythroferrone ratio predicts improvement of anaemia in haemodialysis patients treated with ferric citrate hydrate.
    Hara M; Nakamura Y; Suzuki H; Asao R; Nakamura M; Nishida K; Kenmotsu S; Inagaki M; Tsuji M; Kiuchi Y; Ohsawa I; Goto Y; Gotoh H
    Nephrology (Carlton); 2019 Aug; 24(8):819-826. PubMed ID: 30239062
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Alterations of erythropoiesis in Covid-19 patients: prevalence of positive Coombs tests and iron metabolism.
    Schmitz L; Pirotte M; Lebeau A; Ernst M; Fillet M; Devey A; Schmitt J; Cobraiville G; Binsfeld M; Gofflot S; Beguin Y; Vertenoeil G
    Ther Adv Hematol; 2023; 14():20406207231199837. PubMed ID: 37780945
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Iron regulatory hormone hepcidin decreases in chronic heart failure patients with anemia.
    Matsumoto M; Tsujino T; Lee-Kawabata M; Naito Y; Akahori H; Sakoda T; Ohyanagi M; Tomosugi N; Masuyama T
    Circ J; 2010 Feb; 74(2):301-6. PubMed ID: 20019408
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Iron status in patients with chronic heart failure.
    Jankowska EA; Malyszko J; Ardehali H; Koc-Zorawska E; Banasiak W; von Haehling S; Macdougall IC; Weiss G; McMurray JJ; Anker SD; Gheorghiade M; Ponikowski P
    Eur Heart J; 2013 Mar; 34(11):827-34. PubMed ID: 23178646
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Anemia of Inflammation during Human Pregnancy Does Not Affect Newborn Iron Endowment.
    Abioye AI; Park S; Ripp K; McDonald EA; Kurtis JD; Wu H; Pond-Tor S; Sharma S; Ernerudh J; Baltazar P; Acosta LP; Olveda RM; Tallo V; Friedman JF
    J Nutr; 2018 Mar; 148(3):427-436. PubMed ID: 29546300
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia.
    Sasu BJ; Cooke KS; Arvedson TL; Plewa C; Ellison AR; Sheng J; Winters A; Juan T; Li H; Begley CG; Molineux G
    Blood; 2010 Apr; 115(17):3616-24. PubMed ID: 20053755
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Low circulatory Fe and Se levels with a higher IL-6/IL-10 ratio provide nutritional immunity in tuberculosis.
    Kaushik SR; Sahu S; Guha H; Saha S; Das R; Kupa RU; Kapfo W; Deka T; Basumatary R; Thong A; Dasgupta A; Goswami B; Pandey AK; Saikia L; Khamo V; Das A; Nanda RK
    Front Immunol; 2022; 13():985538. PubMed ID: 36713405
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Iron homeostasis during anemia of inflammation: a prospective study of patients with tuberculosis.
    Cercamondi CI; Stoffel NU; Moretti D; Zoller T; Swinkels DW; Zeder C; Mhimibra F; Hella J; Fenner L; Zimmermann MB
    Blood; 2021 Oct; 138(15):1293-1303. PubMed ID: 33876222
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The target hemoglobin content values of reticulocytes for efficient anemia improvement are achieved by low ferritin levels and moderate transferrin saturation: a retrospective observational study.
    Ogawa C; Tsuchiya K; Tomosugi N; Shimada K; Kanda F; Maeda K
    Hematology; 2020 Dec; 25(1):71-78. PubMed ID: 32009585
    [No Abstract]   [Full Text] [Related]  

  • 73. Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis.
    Cazzola M; Ponchio L; de Benedetti F; Ravelli A; Rosti V; Beguin Y; Invernizzi R; Barosi G; Martini A
    Blood; 1996 Jun; 87(11):4824-30. PubMed ID: 8639855
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The anemia of familial Mediterranean fever disease.
    Celkan T; Celik M; Kasapçopur O; Ozkan A; Apak H; Ocak S; Arisoy N; Yildiz I
    Pediatr Hematol Oncol; 2005 Dec; 22(8):657-65. PubMed ID: 16251171
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Iron status and anemia control are related to peritoneal membrane properties in peritoneally dialyzed patients.
    Głogowski T; Wojtaszek E; Malyszko J
    Front Med (Lausanne); 2023; 10():1148094. PubMed ID: 37484854
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Effect of Qingshen Granules on inflammation/hepcidin axis and iron metabolism in patients with renal anemia: a single-center, randomized controlled trial].
    Zhang L; Wang Y; Jin H; Wang D; Wei L; Ren K; Mao Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Oct; 39(10):1155-1159. PubMed ID: 31801712
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A multicenter, randomized clinical trial of IV iron supplementation for anemia of traumatic critical illness*.
    Pieracci FM; Stovall RT; Jaouen B; Rodil M; Cappa A; Burlew CC; Holena DN; Maier R; Berry S; Jurkovich J; Moore EE
    Crit Care Med; 2014 Sep; 42(9):2048-57. PubMed ID: 24797376
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Transferrin Saturation/Hepcidin Ratio Discriminates
    van der Staaij H; Donker AE; Bakkeren DL; Salemans JMJI; Mignot-Evers LAA; Bongers MY; Dieleman JP; Galesloot TE; Laarakkers CM; Klaver SM; Swinkels DW
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163840
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Serum Concentration of Hepcidin as an Indicator of Iron Reserves in Children.
    Ćulafić J; Kolarović J; Pezo L; Čabarkapa V; Nikolić S; Stojadinović A; Solarov MB
    J Med Biochem; 2018 Dec; 37(4):456-464. PubMed ID: 30584405
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hepcidin and Iron Status in Patients With Inflammatory Bowel Disease Undergoing Induction Therapy With Vedolizumab or Infliximab.
    Loveikyte R; Bourgonje AR; van der Reijden JJ; Bulthuis MLC; Hawinkels LJAC; Visschedijk MC; Festen EAM; van Dullemen HM; Weersma RK; van Goor H; van der Meulen-de Jong AE; Dijkstra G
    Inflamm Bowel Dis; 2023 Aug; 29(8):1272-1284. PubMed ID: 36748574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.